{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:47:32Z","timestamp":1787024852975,"version":"build-2736575974"},"reference-count":49,"publisher":"Japan Academy","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Proc. Jpn. Acad., Ser. B","Proceedings of the Japan Academy. Ser. B: Physical and Biological Sciences"],"published-print":{"date-parts":[[2020,4,10]]},"DOI":"10.2183\/pjab.96.013","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T18:07:18Z","timestamp":1586455638000},"page":"159-169","source":"Crossref","is-referenced-by-count":17,"title":["Osteoimmunology \u2014 Bidirectional dialogue and inevitable union of the fields of bone and immunity \u2014"],"prefix":"10.2183","volume":"96","author":[{"given":"Hiroshi","family":"TAKAYANAGI","sequence":"first","affiliation":[{"name":"Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"993","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Tsukasaki, M. and Takayanagi, H. (2019) Osteoimmunology: Evolving concepts in bone-immune interactions in health and disease. Nat. Rev. Immunol. <b>19<\/b>, 626\u2013642.","DOI":"10.1038\/s41577-019-0178-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Okamoto, K., Nakashima, T., Shinohara, M., Negishi-Koga, T., Komatsu, N., Terashima, A.  (2017) Osteoimmunology: The conceptual framework unifying the immune and skeletal systems. Physiol. Rev. <b>97<\/b>, 1295\u20131349.","DOI":"10.1152\/physrev.00036.2016"},{"key":"3","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1210\/endo-123-5-2600","author":"N. Takahashi","year":"1988","unstructured":"3) Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J.M.  (1988) Osteoblastic cells are involved in osteoclast formation. Endocrinology <b>123<\/b>, 2600\u20132602.","journal-title":"Endocrinology","ISSN":"https:\/\/id.crossref.org\/issn\/0013-7227","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","author":"W.S. Simonet","year":"1997","unstructured":"4) Simonet, W.S., Lacey, D.L., Dunstan, C.R., Kelley, M., Chang, M.S., L\u00fcthy, R.  (1997) Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell <b>89<\/b>, 309\u2013319.","journal-title":"Cell","ISSN":"https:\/\/id.crossref.org\/issn\/0092-8674","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","author":"H. Yasuda","year":"1998","unstructured":"5) Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.I., Yano, K., Fujise, N.  (1998) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG\/OCIF inhibits osteoclastogenesis <i>in vitro<\/i>. Endocrinology <b>139<\/b>, 1329\u20131337.","journal-title":"Endocrinology","ISSN":"https:\/\/id.crossref.org\/issn\/0013-7227","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.  (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc. Natl. Acad. Sci. U.S.A. <b>95<\/b>, 3597\u20133602.","DOI":"10.1073\/pnas.95.7.3597"},{"key":"7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","author":"D.L. Lacey","year":"1998","unstructured":"7) Lacey, D.L., Timms, E., Tan, H.L., Kelley, M.J., Dunstan, C.R., Burgess, T.  (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell <b>93<\/b>, 165\u2013176.","journal-title":"Cell","ISSN":"https:\/\/id.crossref.org\/issn\/0092-8674","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","author":"D.M. Anderson","year":"1997","unstructured":"8) Anderson, D.M., Maraskovsky, E., Billingsley, W.L., Dougall, W.C., Tometsko, M.E., Roux, E.R.  (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature <b>390<\/b>, 175\u2013179.","journal-title":"?Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Wong, B.R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M.  (1997) TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. <b>272<\/b>, 25190\u201325194.","DOI":"10.1074\/jbc.272.40.25190"},{"key":"10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","author":"Y.Y. Kong","year":"1999","unstructured":"10) Kong, Y.Y., Yoshida, H., Sarosi, I., Tan, H.L., Timms, E., Capparelli, C.  (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature <b>397<\/b>, 315\u2013323.","journal-title":"?Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sobacchi, C., Frattini, A., Guerrini, M.M., Abinun, M., Pangrazio, A., Susani, L.  (2007) Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat. Genet. <b>39<\/b>, 960\u2013962.","DOI":"10.1038\/ng2076"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Takeuchi, T., Tanaka, Y., Ishiguro, N., Yamanaka, H., Yoneda, T., Ohira, T.  (2016) Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (<i>D<\/i>enosumab) in patients with <i>R<\/i>heumato<i>I<\/i>d arthritis on methotrexate to <i>V<\/i>alidate inhibitory effect on bone <i>E<\/i>rosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial. Ann. Rheum. Dis. <b>75<\/b>, 983\u2013990.","DOI":"10.1136\/annrheumdis-2015-208052"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Takeuchi, T., Tanaka, Y., Soen, S., Yamanaka, H., Yoneda, T., Tanaka, S.  (2019) Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): A randomised, double-blind, placebo-controlled phase 3 trial. Ann. Rheum. Dis. <b>78<\/b>, 899\u2013907.","DOI":"10.1136\/annrheumdis-2018-214827"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Takayanagi, H., Oda, H., Yamamoto, S., Kawaguchi, H., Tanaka, S., Nishikawa, T.  (1997) A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis. Biochem. Biophys. Res. Commun. <b>240<\/b>, 279\u2013286.","DOI":"10.1006\/bbrc.1997.7404"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Takayanagi, H., Iizuka, H., Juji, T., Nakagawa, T., Yamamoto, A., Miyazaki, T.  (2000) Involvement of receptor activator of nuclear factor \u03baB ligand\/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. <b>43<\/b>, 259\u2013269.","DOI":"10.1002\/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W"},{"key":"16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","author":"Y.Y. Kong","year":"1999","unstructured":"16) Kong, Y.Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S.  (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature <b>402<\/b>, 304\u2013309.","journal-title":"?Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/35046102","author":"H. Takayanagi","year":"2000","unstructured":"17) Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K.  (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-\u03b3. Nature <b>408<\/b>, 600\u2013605.","journal-title":"?Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/35046196","author":"J.R. Arron","year":"2000","unstructured":"18) Arron, J.R. and Choi, Y. (2000) Bone versus immune system. Nature <b>408<\/b>, 535\u2013536.","journal-title":"?Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y.  (2006) Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. <b>203<\/b>, 2673\u20132682.","DOI":"10.1084\/jem.20061775"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S.  (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. <b>103<\/b>, 1345\u20131352.","DOI":"10.1172\/JCI5703"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M.S., Dwyer, D.  (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat. Med. <b>13<\/b>, 156\u2013163.","DOI":"10.1038\/nm1538"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Komatsu, N., Okamoto, K., Sawa, S., Nakashima, T., Oh-hora, M., Kodama, T.  (2014) Pathogenic conversion of Foxp3<sup>+<\/sup> T cells into T<sub>H<\/sub>17 cells in autoimmune arthritis. Nat. Med. <b>20<\/b>, 62\u201368.","DOI":"10.1038\/nm.3432"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Tsukasaki, M., Komatsu, N., Nagashima, K., Nitta, T., Pluemsakunthai, W., Shukunami, C.  (2018) Host defense against oral microbiota by bone-damaging T cells. Nat. Commun. <b>9<\/b>, 701.","DOI":"10.1038\/s41467-018-03147-6"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H.  (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell <b>3<\/b>, 889\u2013901.","DOI":"10.1016\/S1534-5807(02)00369-6"},{"key":"25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature02444","author":"T. Koga","year":"2004","unstructured":"25) Koga, T., Inui, M., Inoue, K., Kim, S., Suematsu, A., Kobayashi, E.  (2004) Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature <b>428<\/b>, 758\u2013763.","journal-title":"?Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Negishi-Koga, T., Gober, H.J., Sumiya, E., Komatsu, N., Okamoto, K., Sawa, S.  (2015) Immune complexes regulate bone metabolism through FcR\u03b3 signalling. Nat. Commun. <b>6<\/b>, 6637.","DOI":"10.1038\/ncomms7637"},{"key":"27","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.cell.2007.12.037","author":"M. Shinohara","year":"2008","unstructured":"27) Shinohara, M., Koga, T., Okamoto, K., Sakaguchi, S., Arai, K., Yasuda, H.  (2008) Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell <b>132<\/b>, 794\u2013806.","journal-title":"Cell","ISSN":"https:\/\/id.crossref.org\/issn\/0092-8674","issn-type":"print"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Sato, K., Suematsu, A., Nakashima, T., Takemoto-Kimura, S., Aoki, K., Morishita, Y.  (2006) Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat. Med. <b>12<\/b>, 1410\u20131416.","DOI":"10.1038\/nm1515"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H.  (2005) Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. <b>202<\/b>, 1261\u20131269.","DOI":"10.1084\/jem.20051150"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-Hora, M., Feng, J.Q.  (2011) Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. <b>17<\/b>, 1231\u20131234.","DOI":"10.1038\/nm.2452"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Xiong, J., Onal, M., Jilka, R.L., Weinstein, R.S., Manolagas, S.C. and O\u2019Brien, C.A. (2011) Matrix-embedded cells control osteoclast formation. Nat. Med. <b>17<\/b>, 1235\u20131241.","DOI":"10.1038\/nm.2448"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Danks, L., Komatsu, N., Guerrini, M.M., Sawa, S., Armaka, M., Kollias, G.  (2016) RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation. Ann. Rheum. Dis. <b>75<\/b>, 1187\u20131195.","DOI":"10.1136\/annrheumdis-2014-207137"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Mizoguchi, F., Slowikowski, K., Wei, K., Marshall, J.L., Rao, D.A., Chang, S.K.  (2018) Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat. Commun. <b>9<\/b>, 789.","DOI":"10.1038\/s41467-018-02892-y"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34) Croft, A.P., Campos, J., Jansen, K., Turner, J.D., Marshall, J., Attar, M.  (2019) Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature <b>570<\/b>, 246\u2013251.","DOI":"10.1038\/s41586-018-0824-5"},{"key":"35","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.immuni.2015.10.017","author":"M.M. Guerrini","year":"2015","unstructured":"35) Guerrini, M.M., Okamoto, K., Komatsu, N., Sawa, S., Danks, L., Penninger, J.M.  (2015) Inhibition of the TNF family cytokine RANKL prevents autoimmune inflammation in the central nervous system. Immunity <b>43<\/b>, 1174\u20131185.","journal-title":"Immunity","ISSN":"https:\/\/id.crossref.org\/issn\/1074-7613","issn-type":"print"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36) Hikosaka, Y., Nitta, T., Ohigashi, I., Yano, K., Ishimaru, N., Hayashi, Y.  (2008) The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator. Immunity <b>29<\/b>, 438\u2013450.","DOI":"10.1016\/j.immuni.2008.06.018"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37) Akiyama, T., Shimo, Y., Yanai, H., Qin, J., Ohshima, D., Maruyama, Y.  (2008) The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. Immunity <b>29<\/b>, 423\u2013437.","DOI":"10.1016\/j.immuni.2008.06.015"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Rossi, S.W., Kim, M.Y., Leibbrandt, A., Parnell, S.M., Jenkinson, W.E., Glanville, S.H.  (2007) RANK signals from CD4<sup>+<\/sup>3<sup>\u2212<\/sup> inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla. J. Exp. Med. <b>204<\/b>, 1267\u20131272.","DOI":"10.1084\/jem.20062497"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Nagashima, K., Sawa, S., Nitta, T., Tsutsumi, M., Okamura, T., Penninger, J.M.  (2017) Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiota. Nat. Immunol. <b>18<\/b>, 675\u2013682.","DOI":"10.1038\/ni.3732"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40) Fata, J.E., Kong, Y.Y., Li, J., Sasaki, T., Irie-Sasaki, J., Moorehead, R.A.  (2000) The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell <b>103<\/b>, 41\u201350.","DOI":"10.1016\/S0092-8674(00)00103-3"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41) Hanada, R., Leibbrandt, A., Hanada, T., Kitaoka, S., Furuyashiki, T., Fujihara, H.  (2009) Central control of fever and female body temperature by RANKL\/RANK. Nature <b>462<\/b>, 505\u2013509.","DOI":"10.1038\/nature08596"},{"key":"42","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","author":"D.H. Jones","year":"2006","unstructured":"42) Jones, D.H., Nakashima, T., Sanchez, O.H., Kozieradzki, I., Komarova, S.V., Sarosi, I.  (2006) Regulation of cancer cell migration and bone metastasis by RANKL. Nature <b>440<\/b>, 692\u2013696.","journal-title":"?Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"43","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/endo.141.9.7634","author":"N. Udagawa","year":"2000","unstructured":"43) Udagawa, N., Takahashi, N., Yasuda, H., Mizuno, A., Itoh, K., Ueno, Y.  (2000) Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology <b>141<\/b>, 3478\u20133484.","journal-title":"Endocrinology","ISSN":"https:\/\/id.crossref.org\/issn\/0013-7227","issn-type":"print"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Tsukasaki, M., Hamada, K., Okamoto, K., Nagashima, K., Terashima, A., Komatsu, N.  (2017) LOX fails to substitute for RANKL in osteoclastogenesis. J. Bone Miner. Res. <b>32<\/b>, 434\u2013439.","DOI":"10.1002\/jbmr.2990"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Asano, T., Nakai, Y., Tsutsumi, M., Muro, R., Suematsu, A., Hashimoto, K.  (2019) Soluble RANKL is physiologically dispensable but accelerates tumour metastasis to bone. Nat. Metab. <b>1<\/b>, 868\u2013875.","DOI":"10.1038\/s42255-019-0104-1"},{"key":"46","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.immuni.2016.05.012","author":"A. Terashima","year":"2016","unstructured":"46) Terashima, A., Okamoto, K., Nakashima, T., Akira, S., Ikuta, K. and Takayanagi, H. (2016) Sepsis-induced osteoblast ablation causes immunodeficiency. Immunity <b>44<\/b>, 1434\u20131443.","journal-title":"Immunity","ISSN":"https:\/\/id.crossref.org\/issn\/1074-7613","issn-type":"print"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Negishi-Koga, T., Shinohara, M., Komatsu, N., Bito, H., Kodama, T., Friedel, R.H.  (2011) Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat. Med. <b>17<\/b>, 1473\u20131480.","DOI":"10.1038\/nm.2489"},{"key":"48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nature11000","author":"M. Hayashi","year":"2012","unstructured":"48) Hayashi, M., Nakashima, T., Taniguchi, M., Kodama, T., Kumanogoh, A. and Takayanagi, H. (2012) Osteoprotection by semaphorin 3A. Nature <b>485<\/b>, 69\u201374.","journal-title":"?Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Hayashi, M., Nakashima, T., Yoshimura, N., Okamoto, K., Tanaka, S. and Takayanagi, H. (2019) Autoregulation of osteocyte Sema3A orchestrates estrogen action and counteracts bone aging. Cell Metab. <b>29<\/b>, 627\u2013637.e5.","DOI":"10.1016\/j.cmet.2018.12.021"}],"container-title":["Proceedings of the Japan Academy, Series B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/pjab\/96\/4\/96_PJA9604B-02\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T23:36:23Z","timestamp":1586561783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/pjab\/96\/4\/96_PJA9604B-02\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,10]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2183\/pjab.96.013","relation":{},"ISSN":["0386-2208","1349-2896"],"issn-type":[{"value":"0386-2208","type":"print"},{"value":"1349-2896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,10]]}}}